Other

Debt Securities, Available-for-Sale, Unrealized Loss Position

Neurocrine Biosciences Debt Securities, Available-for-Sale, Unrealized Loss Position increased by 371.5% to $1.58B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 398.0%, from $317.30M to $1.58B. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ2 2021
Last reportedQ1 2026May 5, 2026

How to read this metric

An increase indicates a broader decline in the market value of the debt portfolio relative to its cost basis.

Detailed definition

The aggregate fair value of all debt securities classified as available-for-sale that are currently in an unrealized los...

Peer comparison

Used to gauge the overall sensitivity of the investment portfolio to market price changes.

Metric ID: other_debt_securities_available_for_sale_unrealized_loss_ab3ae9

Historical Data

7 periods
 Q2 '21Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$245.50M$458.70M$317.30M$401.80M$349.80M$335.10M$1.58B
QoQ Change+86.8%-30.8%+26.6%-12.9%-4.2%+371.5%
YoY Change-26.9%+398.0%
Range$245.50M$1.58B
CAGR+246.0%
Avg YoY Growth+185.5%
Median YoY Growth+185.5%

Debt Securities, Available-for-Sale, Unrealized Loss Position at Other Companies

Frequently Asked Questions

What is Neurocrine Biosciences's debt securities, available-for-sale, unrealized loss position?
Neurocrine Biosciences (NBIX) reported debt securities, available-for-sale, unrealized loss position of $1.58B in Q1 2026.
How has Neurocrine Biosciences's debt securities, available-for-sale, unrealized loss position changed year-over-year?
Neurocrine Biosciences's debt securities, available-for-sale, unrealized loss position increased by 398.0% year-over-year, from $317.30M to $1.58B.
What does debt securities, available-for-sale, unrealized loss position mean?
The total market value of all debt investments currently worth less than what was paid for them.